IRIS
FABBRONI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.602
NA - Nord America 1.578
AS - Asia 704
SA - Sud America 114
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 40
OC - Oceania 5
Totale 4.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.543
IT - Italia 380
RU - Federazione Russa 363
GB - Regno Unito 261
SG - Singapore 217
CN - Cina 205
IE - Irlanda 187
BR - Brasile 97
SE - Svezia 94
VN - Vietnam 87
FI - Finlandia 68
DE - Germania 62
UA - Ucraina 60
FR - Francia 50
HK - Hong Kong 50
NL - Olanda 31
KR - Corea 25
BD - Bangladesh 24
IN - India 23
ZA - Sudafrica 19
CA - Canada 16
IQ - Iraq 11
JP - Giappone 11
MX - Messico 10
PL - Polonia 9
TR - Turchia 9
ES - Italia 6
AR - Argentina 5
AT - Austria 5
AU - Australia 5
BE - Belgio 5
CI - Costa d'Avorio 5
PK - Pakistan 5
UZ - Uzbekistan 5
EG - Egitto 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
NG - Nigeria 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
HR - Croazia 3
ID - Indonesia 3
MA - Marocco 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
GR - Grecia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.044
Salva come PNG Salva come JPEG
Città #
Dallas 252
Southend 223
Dublin 189
Singapore 148
Ashburn 140
Moscow 110
Menlo Park 96
San Jose 93
Santa Clara 84
Chandler 75
Fairfield 53
Helsinki 52
Jacksonville 52
Milan 51
Hong Kong 49
Council Bluffs 46
Beijing 45
The Dalles 36
Rome 32
New York 31
Ann Arbor 30
Hefei 29
Wilmington 27
Hanoi 26
Los Angeles 26
Seattle 25
Houston 24
Seoul 24
Siena 24
Woodbridge 24
Cambridge 23
Ho Chi Minh City 22
Princeton 18
Shanghai 17
Johannesburg 16
São Paulo 16
Munich 14
Columbus 13
Lauterbourg 13
Nanjing 13
Buffalo 12
Chicago 12
Shenyang 12
Venezia 12
Düsseldorf 11
Boardman 10
Dearborn 10
Florence 10
Tokyo 10
Atlanta 9
Denver 9
Orem 8
San Diego 8
Washington 8
San Mateo 7
Warsaw 7
Bengaluru 6
Chennai 6
Haiphong 6
London 6
Toronto 6
Turku 6
Abidjan 5
Boston 5
Brooklyn 5
Brussels 5
Portsmouth 5
San Francisco 5
Abuja 4
Amman 4
Baghdad 4
Bari 4
Genoa 4
Mexico City 4
Modena 4
Naples 4
Tashkent 4
Vienna 4
Zhengzhou 4
Ancona 3
Barnet 3
Brasília 3
Brno 3
Cagliari 3
Cairo 3
Catania 3
Charlotte 3
Crotone 3
Hebei 3
Jiaxing 3
Jinan 3
Kunming 3
Montagnana 3
Montreal 3
Nanchang 3
Nuremberg 3
Padova 3
Phoenix 3
Piscataway 3
Redondo Beach 3
Totale 2.609
Salva come PNG Salva come JPEG
Nome #
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 490
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 302
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 301
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 289
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 267
Joint lavage and pseudogout 246
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 238
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 237
Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus: A case report and review of the literature 217
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 204
Treatment of erosiveosteoarthritis of the hands by intra-articular infliximab injections: a pilotstudy. 202
Baricitinib retention rate: ‘real-life’ data from a mono-centric cohort of patients affected by rheumatoid arthritis 199
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience 196
Effectiveness of Adalimumab in non-radiographic axial spondyloarthritis: evaluation of clinical and magnetic resonance imaging outcomes in a monocentric cohort 173
Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report 120
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement 108
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis 105
null 98
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 95
Totale 4.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022154 0 0 10 19 21 3 7 7 9 13 28 37
2022/2023281 13 31 35 35 29 63 16 15 30 5 7 2
2023/2024384 9 8 33 32 31 82 111 11 8 5 13 41
2024/2025634 23 26 98 22 73 51 26 47 44 29 57 138
2025/20261.719 115 187 217 262 341 141 166 30 52 71 37 100
2026/2027127 54 35 38 0 0 0 0 0 0 0 0 0
Totale 4.087